Medline (MDLN) announced that certain selling stockholders affiliated with Blackstone, Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority, have commenced an underwritten public offering of 60M shares of Medline’s Class A common stock pursuant to a registration statement filed with the SEC. Medline is not selling any shares of Class A common stock in the offering and will not receive any of the proceeds from the sale. Goldman Sachs & Co., Morgan Stanley, BofA Securities and J.P. Morgan are acting as global coordinators and joint bookrunning managers, and Blackstone Capital Markets is acting as co-manager for the proposed offering.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLN:
- Medline files to sell 60M shares of Class A common stock for holders
- AI Models Turn Cautious as MDLN Faces Downgrades on Valuation and Weak Technicals
- Tigress Financial ups Medline price target, sees buying opportunity
- Medline price target lowered to $42 from $48 at Deutsche Bank
- Medline price target lowered to $54 from $56 at Bernstein